148 related articles for article (PubMed ID: 23288585)
1. Full-field electroretinography under general anesthesia in retinoblastoma.
Sachidanandam R; Krishnakumar S; Gopal L; O'Brien JM; Khetan V; Sen P
Doc Ophthalmol; 2013 Apr; 126(2):149-57. PubMed ID: 23288585
[TBL] [Abstract][Full Text] [Related]
2. Non-selectivity of ERG reductions in eyes treated for retinoblastoma.
Liu CY; Jonna G; Francis JH; Marr BP; Abramson DH; Brodie SE
Doc Ophthalmol; 2014 Feb; 128(1):13-23. PubMed ID: 24213436
[TBL] [Abstract][Full Text] [Related]
3. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.
Brodie SE; Pierre Gobin Y; Dunkel IJ; Kim JW; Abramson DH
Doc Ophthalmol; 2009 Aug; 119(1):13-22. PubMed ID: 19169884
[TBL] [Abstract][Full Text] [Related]
4. Electroretinographic changes in the inner retinal layers of the retained eyes of patients with sporadic unilateral retinoblastoma.
Lubiński W; Zajaczek S; Sych Z; Penkala K; Palacz O; Lubiński J
Ophthalmic Genet; 2002 Jun; 23(2):99-107. PubMed ID: 12187428
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of light- and dark-adapted ERGs using a mydriasis-free, portable system: clinical classifications and normative data.
Liu H; Ji X; Dhaliwal S; Rahman SN; McFarlane M; Tumber A; Locke J; Wright T; Vincent A; Westall C
Doc Ophthalmol; 2018 Dec; 137(3):169-181. PubMed ID: 30357588
[TBL] [Abstract][Full Text] [Related]
6. Retinal reattachment and ERG recovery after ophthalmic artery chemosurgery for advanced retinoblastoma in eyes with minimal baseline retinal function.
Abdelhakim AH; Francis JH; Marr BP; Gobin YP; Abramson DH; Brodie SE
Br J Ophthalmol; 2017 May; 101(5):623-628. PubMed ID: 27539090
[TBL] [Abstract][Full Text] [Related]
7. ERG monitoring of retinal function during systemic chemotherapy for retinoblastoma.
Brodie SE; Paulus YM; Patel M; Gobin YP; Dunkel IJ; Marr BP; Abramson DH
Br J Ophthalmol; 2012 Jun; 96(6):877-80. PubMed ID: 22426950
[TBL] [Abstract][Full Text] [Related]
8. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
[TBL] [Abstract][Full Text] [Related]
9. Association of electroretinography with visual outcomes after ophthalmic artery chemosurgery for retinoblastoma in ICRb D and E eyes.
Levin AM; Francis JH; McFadden M; Brodie S; Gobin YP; Abramson DH
PLoS One; 2019; 14(1):e0210647. PubMed ID: 30650131
[TBL] [Abstract][Full Text] [Related]
10. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.
Abramson DH; Fabius AW; Francis JH; Marr BP; Dunkel IJ; Brodie SE; Escuder A; Gobin YP
Ophthalmic Genet; 2017; 38(1):16-21. PubMed ID: 28095092
[TBL] [Abstract][Full Text] [Related]
11. Examinations under anaesthesia as a measure of disease burden in unilateral retinoblastoma: the London experience.
Fabian ID; Shah V; Kapelushnik N; Naeem Z; Onadim Z; Price E; Chowdhury T; Duncan C; Stansfield D; Sagoo M; Reddy MA
Br J Ophthalmol; 2020 Jan; 104(1):17-22. PubMed ID: 30862620
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.
Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ
Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769
[TBL] [Abstract][Full Text] [Related]
13. Number, frequency and time interval of examinations under anesthesia in bilateral retinoblastoma.
Fabian ID; Shah V; Kapelushnik N; Naeem Z; Onadim Z; Price EA; Duncan C; Stansfield D; Sagoo MS; Reddy MA
Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):879-886. PubMed ID: 31900643
[TBL] [Abstract][Full Text] [Related]
14. A phenotype-genotype correlation study of X-linked retinoschisis.
Vincent A; Robson AG; Neveu MM; Wright GA; Moore AT; Webster AR; Holder GE
Ophthalmology; 2013 Jul; 120(7):1454-64. PubMed ID: 23453514
[TBL] [Abstract][Full Text] [Related]
15. Comparison between fullfield electroretinography obtained from handheld and tabletop devices in normal subjects.
Sachidanandam R; Khetan V; Sen P
Can J Ophthalmol; 2015 Apr; 50(2):166-71. PubMed ID: 25863859
[TBL] [Abstract][Full Text] [Related]
16. Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision.
Tsimpida M; Thompson DA; Liasis A; Smith V; Kingston JE; Sagoo MS; Reddy MA
Br J Ophthalmol; 2013 Nov; 97(11):1464-70. PubMed ID: 24037611
[TBL] [Abstract][Full Text] [Related]
17. [Evoked retinal and cortical potentials in children with advanced and resistant retinoblastoma after neoadjuvant polychemotherapy and superselective intra-arterial chemotherapy].
Zueva MV; Tsapenko IV; Saakian SV; Panteleeva OG; Zharua AA; Orlovskaia LS
Vestn Oftalmol; 2014; 130(5):22-9. PubMed ID: 25711058
[TBL] [Abstract][Full Text] [Related]
18. Variability in retinoblastoma genome stability is driven by age and not heritability.
Polski A; Xu L; Prabakar RK; Gai X; Kim JW; Shah R; Jubran R; Kuhn P; Cobrinik D; Hicks J; Berry JL
Genes Chromosomes Cancer; 2020 Oct; 59(10):584-590. PubMed ID: 32390242
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
[TBL] [Abstract][Full Text] [Related]
20. [Electrophysiological evaluation of retinal function after systemic and superselective intra-arterial chemotherapy for retinoblastoma].
Zueva MV; Saakyan SV; Zueva MV; Saakyan SV
Vestn Oftalmol; 2015; 131(5):111-114. PubMed ID: 26845881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]